Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1926
Jacobs Solutions
J
$16.6B
| $3.06M | ﹤0.01% |
+43,627
| New | +$2.94M |
2020 Q2
0 quarters
|
|
1927
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.62B
| $3.04M | ﹤0.01% |
66,400
+55,800
| +526% | +$2.53M |
2019 Q1
5 quarters
|
|
|
TBHC
1928
DELISTED
The Brand House Collective
TBHC
| $3.04M | ﹤0.01% |
1,121,900
+89,900
| +9% | +$111K |
2013 Q2
28 quarters
|
|
1929
AIOS Tech
AIOS
$36.7M
| $3.03M | ﹤0.01% |
920
+181
| +24% | +$455K |
2017 Q4
10 quarters
|
|
1930
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$5.82B
| $3.02M | ﹤0.01% |
+29,900
| New | +$2.98M |
2020 Q2
0 quarters
|
|
1931
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
| $3.01M | ﹤0.01% |
+36,900
| New | +$2.97M |
2020 Q2
0 quarters
|
|
1932
State Street SPDR S&P Biotech ETF
XBI
$9.71B
| $3.01M | ﹤0.01% |
+26,900
| New | +$2.65M |
2020 Q2
0 quarters
|
|
1933
Investors Title Co
ITIC
$537M
| $3.01M | ﹤0.01% |
24,800
-100
| -0.4% | -$12.5K |
2013 Q3
27 quarters
|
|
1934
DELISTED
Intevac Inc
IVAC
| $3.01M | ﹤0.01% |
551,077
-16,700
| -3% | -$86.9K |
2015 Q1
21 quarters
|
|
1935
Byline Bancorp
BY
$1.66B
| $3.01M | ﹤0.01% |
229,600
-104,100
| -31% | -$1.19M |
2018 Q3
7 quarters
|
|
1936
DELISTED
Marlin Business Services Corp
MRLN
| $3.01M | ﹤0.01% |
355,371
+4,801
| +1% | +$37.2K |
2013 Q2
28 quarters
|
|
1937
Sprott
SII
$2.84B
| $3M | ﹤0.01% |
+83,690
| New | +$2.9M |
2020 Q2
0 quarters
|
|
1938
DELISTED
Marine Products Corp
MPX
| $3M | ﹤0.01% |
216,902
-29,900
| -12% | -$314K |
2014 Q4
22 quarters
|
|
|
NH
1939
DELISTED
NantHealth, Inc
NH
| $3M | ﹤0.01% |
43,634
+460
| +1% | +$18.3K |
2017 Q1
13 quarters
|
|
1940
iShares China Large-Cap ETF
FXI
$3.9B
| $3M | ﹤0.01% |
+75,500
| New | +$2.94M |
2020 Q2
0 quarters
|
|
1941
Nexa Resources
NEXA
$1.68B
| $2.99M | ﹤0.01% |
450,000
-50,500
| -10% | -$224K |
2018 Q3
7 quarters
|
|
1942
V2X
VVX
$2.14B
| $2.99M | ﹤0.01% |
60,800
-48,600
| -44% | -$2.35M |
2016 Q2
16 quarters
|
|
1943
DELISTED
Genesis Healthcare, Inc.
GEN
| $2.98M | ﹤0.01% |
4,312,063
-25,210
| -0.6% | -$20.3K |
2015 Q1
21 quarters
|
|
1944
DELISTED
Encore Wire Corp
WIRE
| $2.97M | ﹤0.01% |
60,800
-8,200
| -12% | -$376K |
2018 Q2
8 quarters
|
|
1945
The Mosaic Company
MOS
$6.04B
| $2.96M | ﹤0.01% |
+236,900
| New | +$2.84M |
2020 Q2
0 quarters
|
|
1946
DELISTED
H&E Equipment Services
HEES
| $2.96M | ﹤0.01% |
+160,300
| New | +$2.55M |
2020 Q2
0 quarters
|
|
|
APTX
1947
DELISTED
Aptinyx Inc. Common Stock
APTX
| $2.96M | ﹤0.01% |
709,614
+190,685
| +37% | +$645K |
2019 Q2
4 quarters
|
|
1948
Badger Meter
BMI
$3.72B
| $2.96M | ﹤0.01% |
47,000
-600
| -1% | -$35.6K |
2019 Q4
2 quarters
|
|
1949
Genasys
GNSS
$56.9M
| $2.95M | ﹤0.01% |
607,836
+191,723
| +46% | +$846K |
2014 Q3
23 quarters
|
|
1950
So-Young International
SY
$247M
| $2.95M | ﹤0.01% |
217,700
-3,400
| -2% | -$35.9K |
2020 Q1
1 quarter
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 583 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.